0001213900-22-065696.txt : 20221024
0001213900-22-065696.hdr.sgml : 20221024
20221024101540
ACCESSION NUMBER: 0001213900-22-065696
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221021
FILED AS OF DATE: 20221024
DATE AS OF CHANGE: 20221024
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Novak Alfred J
CENTRAL INDEX KEY: 0001388862
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40804
FILM NUMBER: 221325032
MAIL ADDRESS:
STREET 1: 325 NE 6TH ST
CITY: BOCA RATON
STATE: FL
ZIP: 33432
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Pasithea Therapeutics Corp.
CENTRAL INDEX KEY: 0001841330
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 851591963
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2110 NARCISSUS CT
CITY: VENICE
STATE: CA
ZIP: 90291
BUSINESS PHONE: 8184226172
MAIL ADDRESS:
STREET 1: 2110 NARCISSUS CT
CITY: VENICE
STATE: CA
ZIP: 90291
4
1
ownership.xml
X0306
4
2022-10-21
0
0001841330
Pasithea Therapeutics Corp.
KTTA
0001388862
Novak Alfred J
1111 LINCOLN ROAD, SUITE 500
MIAMI BEACH
FL
33139
1
0
0
0
Stock Option (to acquire Common Stock)
1.06
2022-10-21
4
A
0
100000
0
A
2023-10-21
2032-10-21
Common Stock
100000
100000
D
The Reporting Person was granted 100,000 stock options. The stock options have a ten-year term and vest over two years, subject to Mr. Novak's continued service as a director, one-half vesting on the first anniversary of the grant date, and the remaining 50% vesting on the second anniversary of the grant date.
/s/ Alfred J. Novak
2022-10-24